一个马尔堡变异多发性硬化症病例用rituximab治疗
Melanie Khamlong1, Aishwarya Saripalli1, Noah Yan2
1Internal Medicine, University of California, Los Angeles (UCLA) - Kern Medical, Bakersfield, USA.
Cureus
|September 23, 2025
概括
马尔堡变异性多发性硬化症 (MS) 是具有攻击性的. 这种罕见的病症在一名59岁的妇女中使用Rituximab成功治疗,提供了潜在的新疗法选择.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
背景情况:
- 马尔堡变异性多发性硬化症 (MS) 是一种罕见的,侵袭性的神经系统疾病.
- 诊断依赖于MRI和组织病理学,显示焦点病变.
- 目前的治疗包括皮质类固醇和免疫抑制剂,没有标准的护理.
研究的目的:
- 报告使用Rituximab成功治疗马尔堡变种MS的情况.
- 为了评估Rituximab在罕见的MS亚型中的疗效.
主要方法:
- 一个59岁的妇女的病例报告被诊断为马尔堡变种MS.
- 使用的治疗方法:Rituximab.
- 监测临床过程和治疗反应.
主要成果:
- 被诊断为马尔堡变体MS的患者对rituximab治疗表现出成功的反应.
- 利图西马布为这种侵袭性多发性硬化症变体提供了可行的治疗选择.
结论:
- 利图西马布可以作为马尔堡变异多发性硬化症的有效治疗方法.
- 需要进一步的研究来证实Rituximab在治疗这种罕见的MS亚型中的作用.
相关概念视频
Rheumatic Heart Disease III: Medical Management
289
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
289
Cardiomyopathy IV: Restrictive Cardiomyopathy
461
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
461
Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
493
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
493


